Do you often find that you cannot fulfill your life goals or keep pace with family, work, and everyday social obligations, leaving you feeling misunderstood, overwhelmed, and isolated?
Every patient eventually bears their physical symptoms and pain alone. Unfortunately, society often fails to recognize illnesses proportionally to the actual suffering involved, especially when chronic conditions lack obvious external signs.
Severely ill individuals do not necessarily look sick. At any given stage of sarcoidosis—whether pre-acute, acute, or chronic—manifestations might be limited to debilitating fatigue or remain completely invisible to onlookers.
Even if you show signs of severe exhaustion, dark circles under your eyes, and persistent weariness without having stayed out late, others may simply view you as lethargic or unmotivated. The surrounding environment fails to recognize that these are symptoms of a systemic, multisystem disease.
Even primary care physicians frequently do not suspect a serious multisystem autoimmune condition.
As health deteriorates, patients often experience psychological strain caused by confusion about their own symptoms and cold indifference from society. This additional chronic stress can trigger acute flare-ups and worsen clinical outcomes.
This illustrates the fundamental breakdown in timely diagnostics.
On the other hand, even after receiving a confirmed diagnosis and enduring aggressive pharmacological treatments, little truly gets easier. You live with an illness that fluctuates wildly depending on the immune system's state.
With sarcoidosis, the immune response resembles a erratic speedometer needle—surging and dropping based on environment, airborne allergens, viral infections, temperature shifts, physical exertion, stress levels, nutrition, and countless subtle triggers.
In reality, sarcoidosis resembles an overly reactive plant rather than an easy-to-predict ailment.
Ultimately, patients frequently feel abandoned because public systems lack organized awareness regarding the comprehensive impact of this disease.
Upon first hearing the diagnosis, individuals typically uncover more practical insight from patient forums and websites than within standard healthcare facilities.
How can society demonstrate empathy and awareness when healthcare frameworks themselves rarely provide cognitive, legal, or psychological guidance?
Ignorance breeds fear, stress, denial of fundamental entitlements, and systemic discrimination.
For instance, if someone suffers a sprained ankle, the healthcare system provides prompt diagnostics, focused physical therapy, and clear guidelines on managing temporary limitations. For substantial mobility injuries, social and pension services readily offer financial assistance, orthopedic aids, spa rehabilitation, disability recognition, and accessible parking permits.
In sarcoidosis, structured rehabilitation centered on holistic patient counseling and lifestyle adaptation is practically nonexistent, let alone fair legal recognition. This neglect persists largely because our bones appear intact on the surface, even while long-term medical therapies may quietly erode bone density and vital organs.
The burden of delayed diagnosis
1. The disease smolders silently, eroding organs over time to the point of permanent chronicity or severe complications.
2. The affected individual lacks structured support from doctors, employers, and social circles because, despite their motivation, debilitating symptoms draw skepticism rather than understanding.
Three primary barriers systematically disadvantage individuals with sarcoidosis:
1. The inadequacy and delay of early diagnostic protocols;
2. The near total absence of psychosocial care and community accommodation following diagnosis;
3. Institutional and legislative inequality regarding disability rights and social benefits compared to other chronic conditions.
Until sarcoidosis is recognized by hospital specialists, general practitioners, and pension disability evaluation boards as a comprehensive multisystem disorder, patients will continue facing institutional discrimination.
Sarcoidosis must no longer be ignored in disease prevention, timely evaluation, or the social and disability support systems meant to protect human dignity.
Disability assessment challenges
Because sarcoidosis can impact multiple organs simultaneously, evaluating the true extent of disability is complicated. Medical boards frequently assess single organs in isolation while disregarding systemic fatigue, diffuse pain, peripheral neuropathy, and breathlessness.
For example, if pulmonary function tests show a mild decrease in lung capacity, a pension or disability board may dismiss the case outright, ignoring severe muscle weakness, joint inflammation, or debilitating malaise.
Yet is disability not precisely the inability to maintain normal, independent everyday functioning?
Why do persistent exhaustion, impaired mobility, air hunger, and post-exertional collapse fail to carry proportional weight on standard disability impairment scales?
They fall through the cracks because sarcoidosis does not fit neatly into a single silo—it is neither purely pulmonological, nor exclusively neurological, cardiac, dermatological, or rheumatological.
Most often, patients are categorized solely by lung involvement, where numbers on paper may look deceptively benign compared to advanced oncology or tuberculosis, despite profound everyday disability.
Consequently, sarcoidosis patients often feel marooned on an island of systemic neglect.
One day you might arrive at work without walking canes because joint pain has slightly subsided; four hours later, your body completely collapses from exhaustion. Colleagues and acquaintances are confused, wondering how someone who looked fine hours earlier can suddenly be bedridden. Some think you are exaggerating, while others simply cannot comprehend the fluctuating nature of chronic autoimmune disease.
To some we seem like complainers, while to the broader public our reality remains entirely invisible.
To cut through this psychosocial mist, people living with sarcoidosis and rare systemic diseases rely on patient associations to foster awareness, provide legal education, offer mental health support, and advocate steadfastly for disability rights.
Dino-Josip Ključarić, M.Th.
Full translation of the original Croatian article
The existing guide above is retained in full. The following separate section reproduces the original article, including its statements and examples; it does not validate or update the preceding guide.
The existing English patients’ rights guide above is retained as a separate guide. What follows is a full translation of the original Croatian article by Dino-Josip Ključarić, mag.theol. Its first-person account belongs to that author, not to the reader or website user. The medical and legal statements are the original author’s claims; this translation does not independently verify or update them and is not individual medical or legal advice.
Psychosocial problems and
legal discrimination against people
with sarcoidosis
Do you sometimes or often find that you cannot pursue your own life goals and keep pace with family, work and a normal social life, leaving you without understanding from those around you and feeling downcast and alone?
Every person who is ill ultimately faces their pain alone, but society does not recognise all diseases in proportion to the pain they cause, because each group of diseases manifests differently on the outside.
Seriously ill people do not necessarily look ill, because illness need not be externally visible at every stage. With sarcoidosis, a pre-acute, acute or chronic condition will be visible through fatigue or not visible at all.
Even if you have dark circles and chronic fatigue, without having spent the night drinking and partying, you may appear lethargic, which those around you do not recognise as a symptom of a serious multisystem disease.
Even family doctors will not suspect that this is a dangerous autoimmune disease.
Worsening illness may lead the affected person to psychological imbalance because of their own lack of understanding of the problem and the cold judgement of those around them. This additional stress can cause an acute state, that is, a worsening of the clinical picture.
As you can see, I am talking about the failure of early diagnosis.
In the other case, if you are unquestionably a patient with a confirmed diagnosis undergoing intensive treatment, nothing will change. You have a disease that varies according to the state of your immune system.
With sarcoidosis, the immune system is like a car’s speedometer needle gone haywire. It rises and falls depending on the environment: the amount of allergens, viruses and bacteria in the air, sensitivity to temperature fluctuations, stress and physical exertion, sensitivity to sleep, food and thousands of other factors.
Seen this way, sarcoidosis is more a disease of a “sensitive mimosa” than a “snowflake”.
In the end, you are left alone because there is no system devoted to raising awareness of the extent of this disease.
When you find out that you have sarcoidosis, you will learn more about it on forums and websites than at a healthcare institution.
How can we expect society to be socially sensitive when even the healthcare system provides neither cognitive nor psychological support?
Ignorance is fear, stress, denial of rights and discrimination.
For example, if you dislocate your ankle, the healthcare system will provide diagnosis and treatment, followed by appropriate rehabilitation through physiotherapy and guidance on living with a certain degree of impairment. In more serious cases, through the Social Welfare Centre and the pension and health insurance institutions, you will receive financial assistance, orthopaedic aids, additional rehabilitation at a spa, recognition of disability for pension purposes and a parking sticker.
With sarcoidosis, there is no rehabilitation in the sense of a conversation with the patient about the extent and outcome of the disease; how much further away are we from rights? Precisely because sarcoidosis has not yet broken our bones, although the treatment is also working towards breaking them.
The problem of late diagnosis
1. The disease smoulders and destroys the body to the point of chronic illness or death (5%)
2. The affected person lacks support from doctors, society and family because they feel unwell and unable despite their motivation, and they are subjected to criticism and indifference.
So we are talking about three underlying problems of discrimination against people with sarcoidosis:
1. The problem of ineffective early diagnosis;
2. The problem after a confirmed diagnosis concerning psychosocial assistance and social sensitivity towards those affected;
3. The problem of legality in terms of healthcare and social rights compared with other diseases.
Until sarcoidosis is regarded as a multisystem disease by everyone from hospital specialists and general practitioners to the social worker involved in the pension assessment, patients will be legally discriminated against.
Sarcoidosis is therefore not considered in terms of preventive healthcare through early diagnosis, nor in legal-social or psychosocial terms, even when the diagnosis is firmly established.
The problem of disability assessment
The problem is that sarcoidosis is a multisystem disease that never affects just one organ, and its extent is difficult to assess because doctors do not focus on fatigue, pain in the skin and legs or shortness of breath, but on treating the organ most acutely affected.
For example, sarcoidosis that predominantly threatens the lungs will be recorded in some paperwork with a focus on the lungs and assessment of their capacity. If lung capacity has fallen to 95%, that certainly will not be a criterion for disability.
On the other hand, severe leg pain goes in one ear and out the other for the doctor. The same applies to severe fatigue, weakness and exhaustion.
Is not the very inability to function normally in life already a disability?
Why do weakness, fatigue and exhaustion, difficulty moving, breathlessness and lack of strength during exertion have no place on the list for assessing disability?
They have no place because sarcoidosis is not classified among neurological, cardiac, dermatological, rheumatological, kidney or blood diseases.
Most often, it is placed among lung diseases. In that sense, the lung symptoms alone appear clinically milder than tuberculosis, lung cancer or lymphatic cancer (lymphoma).
In light of these observations, those affected are most often like people on a deserted island whom society does not take seriously.
One morning, for the first time in a long while, I came to work without walking sticks. My legs hurt less. Four hours later, I collapsed. My colleagues were surprised and asked how I could be worse when I had been well in the morning. Some do not see me often and notice that I look worse and more exhausted, while others think my condition is improving because I try to take part in life as much as possible and keep up with the pace of their normality.
To some, we will be hypochondriacs imagining illness and putting on an act; to the others, who are the majority, we are a great unknown.
Because of this psychosocial “fog”, people with sarcoidosis or other rare diseases need an Association to raise social awareness through a programme of education, psychosocial support, promotion of rights and the fight against discrimination.
Dino-Josip Ključarić, mag.theol.